Synergistic cytotoxicity of different alkylating agents for epithelial ovarian cancer
- 11 November 1991
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 49 (5) , 704-710
- https://doi.org/10.1002/ijc.2910490513
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Randomized trial of cyclophosphamide plus cisplatin with or without doxorubicin in ovarian carcinoma: a Gynecologic Oncology Group Study.Journal of Clinical Oncology, 1989
- The Effect of Cisplatin and Fluorouracil on Xenografted Human Squamous Cell Carcinoma of the Head and NeckJAMA Otolaryngology–Head & Neck Surgery, 1988
- The human tumor clonogenic assay used to study ovarian cancersPublished by Springer Nature ,1985
- RANDOMISED TRIAL COMPARING TWO COMBINATION CHEMOTHERAPY REGIMENS (HEXA-CAF VS CHAP-5) IN ADVANCED OVARIAN CARCINOMAThe Lancet, 1984
- A randomized comparison of melphalan versus melphalan plus hexamethylmelamine versus adriamycin plus cyclophosphamide in ovarian carcinomaCancer, 1983
- Reactivity of a monoclonal antibody with human ovarian carcinoma.Journal of Clinical Investigation, 1981
- Exploitable mechanisms in combined radiotherapy-chemotherapy: The concept of additivityInternational Journal of Radiation Oncology*Biology*Physics, 1979
- The Spearman Estimator for Serial Dilution AssaysPublished by JSTOR ,1961